Clinical Trial Search

Primary: Predicted Annual Rate of Change in 10 Year Risk of Fatal or Nonfatal Heart Attack or Stroke — 14.2; 20.8 percentage of annual rate of change

Primary: Change in Foreperiod Effect Task - Processing Speed — 42; 13; 33; 13 response time in msec

Primary: Overall Costs of the Combined Surgical and Medical Treatment — 6881; 11178 Swiss Francs

Primary: Dynamic Gait Index (DGI) — 19; 24; 18.5 units on a scale — p=<0.01

Primary: Bone Mineral Density in FSHD — -0.4 z-score

Primary: Percent Repigmentation of Target Lesion — 0.21; 0.17 percentage of repigmentation

Primary: Number of Specimens for Which a Histologic Diagnosis Could be Made Based Upon the Amount of Tissue Obtained With the Needle — 17; 14 specimens

Primary: Change in HbA1c (Glycosylated Haemoglobin) — -0.88; -1.23; -1.56; -1.70 Percentage of HbA1c — p=<0.0001

Primary: Change From Baseline Air Challenge — -0.98; -0.97 units on a scale

Primary: Patient Satisfaction With the Teaching Method — 8.8; 8.3 units on a scale

Primary: Number of Participants With Decreased Economic Vulnerability — 51; 37 Participants

Primary: Total Number of Smoke-free Days (Biochemically Verified) During Each 5-day Quit Assessment. — 2.7; 2.6 days of smoking abstinence

Primary: The Medication Treatment Step Assigned — 4.03; 4.05 score on a scale

Primary: Number of Participants With Occurrence of Any Treatment Emergent Adverse Event (TEAE) — 277; 27; 275; 267 Participants

Primary: Change in Quality of Women's Health Care (Control Period vs. Intervention Period) — 7.1 percent of care adherent to guidelines